No acute toxicity or graft-versus-host disease (GVHD) of more than grade 2 occurred as a result of adoptive T-cell transfer. In vivo expansion of transferred EBNA-1–specific T cells was observed in ...

Outcomes of patients with multiple myeloma treated at a regional Australian center compared to a metropolitan Australian center. Testing Mayo Clinic’s new 20/20/20 risk stratification model in another ...